Luis Fernando Simoneti
Quick facts
Marketed products
- Ketoprofen and Omeprazole · Rheumatology / Pain Management / Gastroenterology
Ketoprofen inhibits prostaglandin synthesis via COX inhibition to reduce inflammation and pain, while omeprazole suppresses gastric acid production to protect against NSAID-induced ulcers.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: